Etanercept-Induced Myelopathy in a Pediatric Case of Blau Syndrome
Case Reports in Rheumatology · 2011
DOI: 10.1155/2011/134106 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Rheumatology, 2011. Verfasst von Fabiola Caracseghi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Rheumatology Department, Vall d'Hebron University Hospital, P. Vall d'Hebron 119-129, 08035 Barcelona, Spain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Blau syndrome is a rare autoinflammatory disorder within the group of pediatric granulomatous diseases. Mutations in nucleotide-binding oligomerization domain 2 (NOD2/CARD15) are responsible for this condition, which has an autosomal dominant pattern of inheritance and variable expressivity. The clinical picture includes arthritis, uveitis, skin rash, and granulomatous inflammation. Central nervous system involvement is seldom reported, although some isolated cases of seizures, neurosensorial hearing loss, and transient cranial nerve palsy have been described. Treatment consists of nonsteroidal anti-inflammatory drugs, corticosteroids, and immunosuppressive agents, among which anti-tumor-necrosis-factor-alpha (TNF- α ) biologic agents, such as etanercept, play an important role. Among the major adverse effects of TNF- α inhibitors, demyelinating disease, multiple sclerosis, and acute transverse myelitis have been reported in adults. We describe a case of pediatric Blau syndrome affected by etanercept-induced myelopathy, manifesting as a clinical syndrome of transverse myelitis. The patient experienced rapid recovery after etanercept was discontinued. To our knowledge, this is the first such case reported in the literature and, possibly, the one with the latest onset, following 8 years of treatment. We discuss the etiopathogenic mechanisms of this reaction and possible explanations for the imaging findings.
Autor:innen und Institutionen
- Pediatric Rheumatology Department, Vall d'Hebron University Hospital, P. Vall d'Hebron 119-129, 08035 Barcelona, Spain.
Zitieren
APA
Caracseghi, F., Izquierdo-Blasco, J., Sanchez-Montanez, A., Melendo-Perez, S., Roig-Quilis, M., & Modesto, C. (2011). Etanercept-Induced Myelopathy in a Pediatric Case of Blau Syndrome. Case Reports in Rheumatology. https://doi.org/10.1155/2011/134106
Vancouver
Caracseghi F, Izquierdo-Blasco J, Sanchez-Montanez A, Melendo-Perez S, Roig-Quilis M, Modesto C. Etanercept-Induced Myelopathy in a Pediatric Case of Blau Syndrome. Case Reports in Rheumatology. 2011. doi:10.1155/2011/134106
BibTeX
@article{Caracseghi2011,
author = {Caracseghi, Fabiola and Izquierdo-Blasco, Jaume and Sanchez-Montanez, Angel and Melendo-Perez, Susana and Roig-Quilis, Manuel and Modesto, Consuelo},
title = {Etanercept-Induced Myelopathy in a Pediatric Case of Blau Syndrome},
journal = {Case Reports in Rheumatology},
year = {2011},
doi = {10.1155/2011/134106}
}
EUVIMED